The clinical management of anxiety disorders. New York: Oxford University Press, 1991: 79–100Hoehn-Saric, R., & McLeod, D. R. (1991). Clinical management of generalized anxiety disorder. In W. Coryell & G. Winokur (Eds.), The clinical management of anxiety disorders. New York: Oxford ...
To evaluate the prevalence of anxiety disorders in a clinical referred sample of children and adolescents with attention deficit/hyperactivity disorder (ADHD).78 children and adolescents with ADHD according to DSM-IV criteria were investigated with a semi-structured interview (P-CHIPS), complemented by...
Generalized anxiety disorder (GAD) is one of the least studied and least clearly conceptualized of the anxiety disorders. The present article reviews the information which currently exists on the nature and treatment of GAD. An attempt is made to integrate clinical aspects with theoretical conceptualiz...
The primary aim of this study was to model endorsement of ICD-11 anxiety and depression symptoms, using FMM, with data from a representative sample of the Irish adult population to determine if there was a profile consistent with ICD-11 description of ‘Mixed depressive and anxiety disorder’ ...
Generalized anxiety disorder (GAD) is a prevalent condition, associated with extensive psychiatric and medical comorbidity and usually characterized by a chronic course. Although GAD is common, its existence and importance have been neglected for many years in the research arena. GAD commonly presents ...
The purpose was to develop a Japanese version of the Spontaneous Use of Imagery Scale (SUIS-J) and test its clinical utility. Undergraduate students answered the SUIS-J and the Liebowitz Social Anxiety Scale (LSAS-J). Twenty patients with social anxiety disorder (SAD) completed these scales bef...
Objective: This study examined the efficacy and tolerability of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine, for the treatment of patients with generalized anxiety disorder (GAD). Method: Patients were ≥ 18 yea... U Lepola,Esa Leinonen,H Koponen - 《Primary Care Compan...
In conclusion, experimental evidence to date suggests that abecarnil may be a valuable alternative to currently used agents for the treatment of generalised anxiety disorder, particularly if efficacy is maintained at lower dosages. However, clinical trials, including comparisons with benzodiazepines, ...
(for an example of a description with clinical indications, see cited references) [57,58]. Nowadays, WES is recommended as first-tier clinical genetic diagnostic tool for NDD [59], with discussions ongoing for the incorporation of WGS as the first-choice genetic test in NDD [60]. ...
Areas of expertise: –Adjustment and psychological difficulties arising from medical/health conditions (e.g. pain, cancer, sleeping problem, etc.) –Mood Disorders (e.g. Depression, Bipolar Disorder) –Various types of anxiety problems, including those suffering from phobias, panic attacks, health ...